Aran Research & Development (1982)
Company page · Services

Aran Research & Development (1982)

TASE : ARANISIN : IL0010852650Headquarters: CaesareaIFRS accounts · in ₪M

Aran Research & Development (1982) Ltd. engages in the product design and development, and equipment manufacturing businesses for plastics industry in Israel. Based in Caesarea.

Price₪43.27−0.7% · session of 12/11/2026
Market cap₪196Mprice × number of shares
Next resultsno later than 30/11/2026Quarterly report
1-year price+15.0% over the period
Analysis in brief · H1 2026

Aran Research & Development (1982): net income sharply down (−41.2%), sales up (+4.8%), operating income sharply down (−44.0%).

  • Net income sharply down

    Net income: ₪3M, vs. ₪6M a year earlier, i.e. −41.2%.

    H1 2026
  • Sales up

    Revenue: ₪140M, vs. ₪133M a year earlier, i.e. +4.8%.

    H1 2026
  • Operating income sharply down

    Operating income: ₪5M, vs. ₪10M a year earlier, i.e. −44.0%.

    H1 2026
  • Cash flow stable

    Operating cash flow: ₪18M, vs. ₪18M a year earlier, i.e. +1.6%.

    H1 2026
Built automatically from the published figures.
Valuation

What the market pays, vs. the sector

P/E12.1price / net income over 12 months
P/B2.1market cap / equity
Dividend yield8.1%dividends over the last 12 months / price
12-month range₪37.63 – ₪48.87monthly closes

This company's valuation multiples history is being built day by day from now on.

P/E calculated on net income (trailing 12 months: last fiscal year + H1 2026 − same period a year earlier). Sector median: companies in the group tracked here. Prices: Yahoo Finance; market cap cross-checked with the Tel Aviv Stock Exchange for Israeli stocks. These ratios describe a price, not a value: none of them says whether the share is expensive or cheap.

Dividends

Dividend per share, over 5 years

₪0.612021₪0.612022₪1.2320232024₪5.102025₪1.502026 (to date)

Total dividends per share paid each calendar year (4 year(s) out of 5 with a payment). Source: Yahoo Finance. The current year is not complete.

Insiders

Trades by executives and interested parties

11 filing(s) over 12 months · on shares: 10 increase(s) and 0 decrease(s) in holdings.

DateHolderSecurityDirectionQuantityPrice
24/09/2026Cohavit Hamodaot Ltd
Interested party
SharesUp1,068₪48.00Maya ›
23/09/2026Cohavit Hamodaot Ltd
Interested party
SharesUp3,159₪48.20Maya ›
17/09/2026Cohavit Hamodaot Ltd
Interested party
SharesUp5,100₪48.00Maya ›
17/09/2026Etti Rosenberg
Executive
OptionsDown7,500₪20.70Maya ›
09/09/2026Cohavit Hamodaot Ltd
Interested party
SharesUp12,068₪46.20Maya ›
09/09/2026Biton Hovav
Director
SharesUp329₪44.81Maya ›
08/09/2026Mazor Lior
Director
SharesUp9,638₪45.50Maya ›
06/09/2026Biton Hovav
Director
SharesUp130₪46.00Maya ›
02/09/2026A.B AFULA LTD
Interested party
SharesUp297₪43.95Maya ›
01/09/2026Cohavit Hamodaot Ltd
Director
SharesUp32,318₪41.90Maya ›
31/08/2026Cohavit Hamodaot Ltd
Director
SharesUp4,139₪41.20Maya ›

Filings submitted on Maya (executives, directors, shareholders above 5%). An increase or decrease in holdings may come from a purchase or sale on the exchange, but also from a grant or exercise of options (price "—": grant with no price). Bonds excluded. For details, see the filing on Maya.

Follow earnings · WhatsApp group TA-125Details ▾
WhatsApp group · TA-125

Every report from a TA-125 company, analyzed the same day: key figures and year-on-year change, analysis in brief, share price reaction. One daily summary during earnings season.

Detailed figures and history
The figures

Financial summary

S1 2026S1 2025FY 2025
Total assets210193213
Current assets167144169
Non-current assets424944
Equity98107105
of which minority interests6610
Current liabilities966189
Non-current liabilities162519
Revenue140133263
Gross profit212446
Operating income51032
Pre-tax income6933
Net income5725
Net income (attributable to shareholders)3619
Dividends paid−7−4−14
Operating cash flow181858

In millions of shekels. The "H1" columns cover the first six months of the year.

Ratios

Calculated from these figures

S1 2026S1 2025FY 2025
Gross margin15.1%18.2%17.7%
Operating margin3.9%7.3%12.1%
Net margin2.5%4.5%7.1%
Current ratio (current assets / current liabilities)1,7 x2,4 x1,9 x
Equity / total assets46.6%55.4%49.3%

The 5-year history, charts and cross-check models are coming for companies listed only in Tel Aviv: each new filing on Maya is kept and enriches the page.

Company overview

Aran Research & Development (1982) Ltd. engages in the product design and development, and equipment manufacturing businesses for plastics industry in Israel. It operates through Investments in Ventures and Start-Up Companies; Sale of Equipment and Raw Materials; and Product Development, Design, and Manufacturing Services segments. The company develops various medical devices; water devices and fluid management systems, including pressure and flow regulators, electric and hydraulic valves, air release valves, sprinklers, drippers, taps, water meters, filters, check valves, electronic controllers, and testing devices; and measurement and weighing devices, specialty printers, automatic beverage machines, computerized shopping carts and self-checkout kiosks, industrial and communication devices, and batteries. It also provides plastic sheets for agriculture, food and industrial packaging, pipes, and other technical products; technical support, training, analysis, after sales, logistics, and other services; and technological consulting, and software and computing personnel placement services. In addition, the company supplies machines and equipment, such as injection molding machines, robotics and automation, injection molds, hot runner systems, drying dosing and conveying systems, plasticizing screws barrels, ultrasonic welding and cleaning, and raw materials; designs, manufactures, and imports injection molds; and invests in medical start-up companies.

Source: official company profile (Yahoo Finance), summary. Website: www.aran-rd.com

Sources
Information, no recommendation. This site presents figures published by companies and calculations based on those figures. It is not investment advice, nor a recommendation to buy or sell, nor a valuation of the companies. Always check the original reports.